# Cathelicidin LL-37 Relation to Potentially Malignant Lesions

> **NCT06219330** · — · COMPLETED · sponsor: **Fayoum University** · enrollment: 45 (actual)

## Conditions studied

- Oral Potentially Malignant Lesions

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06219330
- **Lead sponsor:** Fayoum University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-01
- **Primary completion:** 2023-10-30
- **Final completion:** 2023-11-15
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06219330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06219330, "Cathelicidin LL-37 Relation to Potentially Malignant Lesions". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06219330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*